Pacira (PCRX) Rips Over 22% Following Q3 Results, EXPAREL FDA Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/8/2026

1. TTD
2. NET
3. ABNB
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. U

Go back to Pacira (PCRX) Rips Over 22% Following Q3 Results, EXPAREL FDA Approval
PACIRA (NASDAQ: PCRX) Delayed: 25.02 -0.56 (2.19%)
Previous Close $25.58    52 Week High $80.25 
Open $25.67    52 Week Low $30.25 
Day High $25.68    P/E N/A 
Day Low $24.94    EPS $-2.08 
Volume 603,210